PepGen Inc. (NasdaqGS: PEPG)
Health Care · Biotechnology · US
$2.62
+10.08% today · -47.9% 1Y
PepGen Inc. (NasdaqGS: PEPG) operates in the Biotechnology industry within the Health Care sector. The company is valued at $181.46M and employs 57 people.
Over the last twelve months the share price has lost 47.9%, trading between 1.31 and 7.80.
Tweenvest scores PepGen Inc. across four factors: quality 36/100, value 50/100. Its strongest factor is value.
PEPG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $181.46M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.19
- Dividend yield
- —
- Beta (5Y)
- 2.01
- 52-week high
- $7.80
- 52-week low
- $1.31
- Avg volume (3M)
- —
- Shares outstanding
- 69.26M
- Employees
- 57
- Next earnings
- —
About PepGen Inc.
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
- ISIN
- US7133171055
- Founded
- 2018
- Listed since
- May 6, 2022
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thor Medical ASAOB: TRMED | $196.75M | Nkr4.46 | -1.00% |
| IntoCell, Inc.KOSDAQ: A287840 | $193.53M | ₩17,320.00 | -4.04% |
| Precision BioSciences, Inc.NasdaqCM: DTIL | $185.48M | $6.72 | +4.51% |
| Adagene Inc.NasdaqGM: ADAG | $185.32M | $2.76 | -3.16% |
| Hester Biosciences LimitedBSE: 524669 | $179.48M | Rs2,041.90 | -4.61% |
| Compass Therapeutics, Inc.NasdaqCM: CMPX | $178.83M | $0.99 | +15.91% |
| Uwell Biopharma, Inc.TPEX: 7902 | $175.67M | NT$28.00 | -4.92% |
| GC Genome CorporationKOSDAQ: A340450 | $173.64M | ₩9,870.00 | +11.15% |
Figures last refreshed Oct 11, 2026.